Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage | Zendy

Tobias Pilgaard Ottosen | Zendy; Miriam Grijota | Zendy; Morten Lock Hansen | Zendy; Axel Brandes | Zendy; Dorte Damgaard | Zendy; Steen Husted | Zendy; Søren Paaske Johnsen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage

Author(s) -

Tobias Pilgaard Ottosen,

Miriam Grijota,

Morten Lock Hansen,

Axel Brandes,

Dorte Damgaard,

Steen Husted,

Søren Paaske Johnsen

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.012945

Subject(s) - medicine , intracerebral hemorrhage , hazard ratio , antithrombotic , confidence interval , stroke (engine) , cohort study , surgery , subarachnoid hemorrhage , mechanical engineering , engineering

The effectiveness and safety of antithrombotic therapy (AT) among patients with a history of intracerebral hemorrhage remain uncertain. We therefore determined the prevalence of indication for AT among patients hospitalized with first-time intracerebral hemorrhage and examined the impact of subsequent AT use on the long-term clinical outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research